- Home
- TEAD vs VNDA Comparison
TEAD vs VNDA Comparison
Compare TEAD & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEAD
- VNDA
- Stock Information
- Founded
- TEAD 2006
- VNDA 2002
- Country
- TEAD United States
- VNDA United States
- Employees
- TEAD N/A
- VNDA N/A
- Industry
- TEAD
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- TEAD
- VNDA Health Care
- Exchange
- TEAD NYSE
- VNDA Nasdaq
- Market Cap
- TEAD 241.4M
- VNDA 286.4M
- IPO Year
- TEAD N/A
- VNDA 2006
- Fundamental
- Price
- TEAD $2.59
- VNDA $4.67
- Analyst Decision
- TEAD Hold
- VNDA Strong Buy
- Analyst Count
- TEAD 1
- VNDA 3
- Target Price
- TEAD $3.40
- VNDA $15.33
- AVG Volume (30 Days)
- TEAD 336.1K
- VNDA 459.2K
- Earning Date
- TEAD 08-07-2025
- VNDA 07-31-2025
- Dividend Yield
- TEAD N/A
- VNDA N/A
- EPS Growth
- TEAD N/A
- VNDA N/A
- EPS
- TEAD N/A
- VNDA N/A
- Revenue
- TEAD $959,268,000.00
- VNDA $201,351,000.00
- Revenue This Year
- TEAD $65.64
- VNDA $16.86
- Revenue Next Year
- TEAD $5.29
- VNDA $39.78
- P/E Ratio
- TEAD N/A
- VNDA N/A
- Revenue Growth
- TEAD 4.15
- VNDA 13.37
- 52 Week Low
- TEAD $2.32
- VNDA $3.81
- 52 Week High
- TEAD $7.87
- VNDA $6.04
- Technical
- Relative Strength Index (RSI)
- TEAD N/A
- VNDA 47.29
- Support Level
- TEAD N/A
- VNDA $4.60
- Resistance Level
- TEAD N/A
- VNDA $4.85
- Average True Range (ATR)
- TEAD 0.00
- VNDA 0.19
- MACD
- TEAD 0.00
- VNDA -0.03
- Stochastic Oscillator
- TEAD 0.00
- VNDA 15.91
About TEAD TEADS HLDG CO
Teads Holding Co is the omnichannel outcomes platform for the open internet, driving full-funnel results for marketers across premium media. Its Focus on meaningful business outcomes for branding and performance objectives, the combined company ensures value is driven with every media dollar by leveraging predictive AI technology to connect quality media, beautiful brand creative, and context-driven addressability and measurement.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.